StonvexLoading…
StonvexStonvexStonvexCore line items from IMMR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-04-30 | Annual 2025 2025-01-31 | Annual 2024 2024-10-31 | Annual 2024 2024-07-31 |
|---|---|---|---|---|
Revenue | $1.56B | $1.27B | $799.74M | $89.94M |
Operating Income | $118.02M | $119.23M | $83.99M | $-9.64M |
Net Income | $64.28M | $81.94M | $57.88M | $-246.00K |
EPS (Diluted) | $1.90 | $2.50 | $1.77 | $-0.01 |
Total Assets | $1.10B | $1.44B | $1.36B | Not available |
Total Liabilities | $543.58M | $849.97M | $876.60M | Not available |
Cash & Equivalents | $72.61M | $85.23M | $97.86M | Not available |
Free Cash Flow OCF − CapEx | $-68.81M | $-115.81M | $-69.56M | Not available |
Shares Outstanding | 32.50M | 32.40M | 48.69M | 31.97K |